[go: up one dir, main page]

FR3129407B1 - METHOD FOR DETECTING THE PRESENCE OF A PATHOGEN AND DETERMINING ITS CHARACTERISTICS IN HUMAN AND ANIMAL HEALTH - Google Patents

METHOD FOR DETECTING THE PRESENCE OF A PATHOGEN AND DETERMINING ITS CHARACTERISTICS IN HUMAN AND ANIMAL HEALTH Download PDF

Info

Publication number
FR3129407B1
FR3129407B1 FR2112554A FR2112554A FR3129407B1 FR 3129407 B1 FR3129407 B1 FR 3129407B1 FR 2112554 A FR2112554 A FR 2112554A FR 2112554 A FR2112554 A FR 2112554A FR 3129407 B1 FR3129407 B1 FR 3129407B1
Authority
FR
France
Prior art keywords
pathogen
human
detecting
determining
animal health
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR2112554A
Other languages
French (fr)
Other versions
FR3129407A1 (en
Inventor
Marc Masson
Carole Bloes
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Anova Plus
Original Assignee
Anova Plus
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Anova Plus filed Critical Anova Plus
Priority to FR2112554A priority Critical patent/FR3129407B1/en
Priority to PCT/EP2022/083241 priority patent/WO2023094579A1/en
Publication of FR3129407A1 publication Critical patent/FR3129407A1/en
Application granted granted Critical
Publication of FR3129407B1 publication Critical patent/FR3129407B1/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/686—Polymerase chain reaction [PCR]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/689—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6888—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms
    • C12Q1/6895—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for detection or identification of organisms for plants, fungi or algae
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Virology (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)

Abstract

L’invention a trait au domaine du diagnostic pour la détection des pathogènes en santé humaine et animale. Plus particulièrement, elle concerne une méthode de détection de la présence d’un pathogène et de détermination de ses caractéristiques de virulence et de résistance aux traitements pour une prise en charge adaptée. Elle concerne également un kit de diagnostic prêt-à-l’emploi pour la mise en œuvre de la méthode.The invention relates to the field of diagnostics for the detection of pathogens in human and animal health. More particularly, it relates to a method for detecting the presence of a pathogen and determining its virulence and treatment resistance characteristics for appropriate management. It also relates to a ready-to-use diagnostic kit for implementing the method.

FR2112554A 2021-11-25 2021-11-25 METHOD FOR DETECTING THE PRESENCE OF A PATHOGEN AND DETERMINING ITS CHARACTERISTICS IN HUMAN AND ANIMAL HEALTH Active FR3129407B1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
FR2112554A FR3129407B1 (en) 2021-11-25 2021-11-25 METHOD FOR DETECTING THE PRESENCE OF A PATHOGEN AND DETERMINING ITS CHARACTERISTICS IN HUMAN AND ANIMAL HEALTH
PCT/EP2022/083241 WO2023094579A1 (en) 2021-11-25 2022-11-25 Method for detecting the presence of a pathogen and determining the characteristics thereof with respect to human and animal health

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR2112554 2021-11-25
FR2112554A FR3129407B1 (en) 2021-11-25 2021-11-25 METHOD FOR DETECTING THE PRESENCE OF A PATHOGEN AND DETERMINING ITS CHARACTERISTICS IN HUMAN AND ANIMAL HEALTH

Publications (2)

Publication Number Publication Date
FR3129407A1 FR3129407A1 (en) 2023-05-26
FR3129407B1 true FR3129407B1 (en) 2024-12-13

Family

ID=81345943

Family Applications (1)

Application Number Title Priority Date Filing Date
FR2112554A Active FR3129407B1 (en) 2021-11-25 2021-11-25 METHOD FOR DETECTING THE PRESENCE OF A PATHOGEN AND DETERMINING ITS CHARACTERISTICS IN HUMAN AND ANIMAL HEALTH

Country Status (2)

Country Link
FR (1) FR3129407B1 (en)
WO (1) WO2023094579A1 (en)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2008535518A (en) 2005-04-14 2008-09-04 アプレラ コーポレイション 3 'modified oligonucleotides containing pseudoisocytosine nucleobase derivatives and their application as primers or probes
US9353393B2 (en) 2012-02-15 2016-05-31 General Electric Company Methods and kits for reducing non-specific nucleic acid amplification
KR102281854B1 (en) * 2015-12-29 2021-07-26 국민대학교산학협력단 A method and test kit for detecting microorganisms using pcr product
US10689716B1 (en) * 2020-03-19 2020-06-23 University Of Miami Materials and methods for detecting coronavirus
US20210340635A1 (en) * 2020-03-19 2021-11-04 University Of Miami Materials and methods for detecting coronavirus
CN113604607A (en) * 2021-07-28 2021-11-05 江苏奈尔森生物技术有限公司 ERA nucleic acid test strip amplification kit for rapidly detecting feline herpesvirus, preparation method and detection method

Also Published As

Publication number Publication date
WO2023094579A1 (en) 2023-06-01
FR3129407A1 (en) 2023-05-26

Similar Documents

Publication Publication Date Title
EA201890724A1 (en) METHODS OF DIAGNOSTICS AND EVALUATION OF NONALCOHOLIC STEATOGEPATITIS
CY1116089T1 (en) CD73 AS A INDICATOR FOR MONITORING DISEASE DEVELOPMENT AND TREATMENT OF TREATMENT EFFICIENCY
AR080361A1 (en) IDENTIFICATION, EVALUATION AND THERAPY OF CANCERES WITH INNATE RESISTANCE OR ACQUIRED TO QUINASA INHIBITORS OF ANAPLASIC LYMPHOMA (ALK)
FR3129407B1 (en) METHOD FOR DETECTING THE PRESENCE OF A PATHOGEN AND DETERMINING ITS CHARACTERISTICS IN HUMAN AND ANIMAL HEALTH
FR3060755B1 (en) METHOD FOR DIAGNOSING SKIN WITH SIGNS OF DRYNESS
MX2021000069A (en) Compositions and methods for treating inflammatory bowel disease.
FR3109819A1 (en) Method for detecting the presence of a pathogen in a biological fluid
ATE492815T1 (en) DIAGNOSTIC BIOMOLECULE(S)
Lee et al. Real-time optical detection of endodontic infection using bacterial autofluorescence
IN2014CN03455A (en)
EA201490576A1 (en) MOLECULAR MARKER FOR EARLY DIAGNOSTICS OF PLESUS MESOTHELIOMAS IN PATIENTS AND METHODS FOR ANALYSIS OF ITS EXPRESSION
EP4286538A3 (en) Pathogen diagnostic test
MX2013009209A (en) METHOD FOR ANALYZING PLATE.
BR112018076005A2 (en) isolated monoclonal antibody, method for measuring the level of gamma-glutamyl-l-epsilon-lysine (gel), ex vivo method for monitoring apoptosis, use of a specific monoclonal antibody for gamma-glutamyl-l-epsilon-lysine (gel) ), methods for monitoring the efficacy of apoptosis-inducing treatment, method of treating an unregulated apoptosis-associated disease, apoptosis monitoring kit, sepsis treatment method, and side-flow immunoassay device
BASER et al. Evaluation of periodontal disease awareness by comparing self reports and clinical measurements of patients at İstanbul University Faculty of Dentistry
BR112022003425A2 (en) Method and diagnostic kit for determining whether a subject suspected of having a brain tumor has a glioma or a lymphoma, computer-readable medium, and, method of facilitating the selection of treatment for a subject suspected of having a brain tumor
RU2014152102A (en) A method for assessing human health in predicting the course of an infectious disease
RU2011116505A (en) METHOD FOR DIAGNOSTIC OF VARIOUS FORMS OF ACUTE PYELONEPHRITIS
AR078002A1 (en) USE OF CATEPSIN H TO IDENTIFY COMPOUNDS THAT MODULATE NEUROPATHIC PAIN
CY1124477T1 (en) BIO-SENSOR AND METHOD FOR THE EARLY DIAGNOSIS OF GLAUCOMA
UA115637C2 (en) METHOD OF ASSESSMENT OF THE EFFICIENCY OF TREATMENT OF PATIENTS WITH ACUTE BACTERIAL MENINGITIS WITH BRAIN INJURY
RU2011130168A (en) METHOD FOR STERILIZING COMPOTE FROM CHERRY
AR047042A1 (en) METHOD OF PREPARATION OF BODY LIQUIDS AS A CONDITION FOR DETECTION OF PRION-PROTEINS MODIFIED PATOLOGICALLY (PRPSC)
RU2011130338A (en) METHOD FOR STERILIZING COMPOTE FROM TKEMALI, Cherry-plum, Mirabeli and Dogwood
UA146187U (en) METHOD OF DIAGNOSING SUBCLINICAL HYPOTHIREOSIS IN PATIENTS WITH ARTERIAL HYPERTENSION

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20230526

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4